Mdma molecule:

Image from PubChem

Mdma Clinical Trials

A Multicenter, 12-month, Open-label, Single-arm, Safety Study Of Oxycodone Hydrochloride And Naltrexone Hydrochloride Extended-release Capsules In Subjects With Moderate To Severe Chronic Noncancer Pain

To see complete record on, please visit this link

Id: NCT01428583

Organisation Name: Pfizer

Overal Status: Completed

Start Date: December 2010

Last Update: November 21, 2016

Lead Sponsor: Pfizer

Brief Summary: The study will provide information to assess the benefits versus risks of extended exposure to oxycodone HCl and naltrexone HCl extended-release capsules in a chronic noncancer pain population.

  • Chronic Noncancer Pain

Total execution time in seconds: 0.31900405883789